The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Mesoblast Limited(NASDAQ:MESO) 
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine...
Website: http://www.mesoblast.com
Founded: 2004
Full Time Employees: 102
CEO: Silviu Itescu
Sector: Healthcare
Industry: Biotechnology
Mesoblast Days Payable Outstanding ttm (DPO)
Mesoblast Days Receivable Outstanding ttm (DSO)
Mesoblast Days Inventory Outstanding ttm (DIO)
Mesoblast Op Cashflow Per Share ttm
Mesoblast Free Cashflow Per Share ttm
Mesoblast Cash Per Share ttm
Mesoblast P/S ratio ttm
Mesoblast (GAAP) P/E ratio ttm
Mesoblast P/B ratio ttm
No extra charts and metrics for this ticker.